Complications associated with chemotherapy in testicular cancer management (Q37853021)

24 August 2017

1 reference

title

Complications associated with chemotherapy in testicular cancer management (English)

1 reference

24 August 2017

1 reference

1 reference

Chunkit Fung

1

1 reference

PubMed ID

21403662

24 August 2017

David J Vaughn

series ordinal

2

1 reference

PubMed ID

21403662

24 August 2017

language of work or name

English

0 references

publication date

15 March 2011

1 reference

24 August 2017

Nature Reviews Urology

1 reference

24 August 2017

8

1 reference

24 August 2017

4

1 reference

24 August 2017

213-222

1 reference

https://scigraph.springernature.com/pub.10.1038/nrurol.2011.26

24 August 2017

0 references

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Testicular cancer survivorship: research strategies and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Update on testicular germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Etoposide and cisplatin chemotherapy for metastatic good-risk germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Medical treatment of advanced testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Quality of life in good prognosis patients with metastatic germ cell cancer: a prospective study of the European Organization for Research and Treatment of Cancer Genitourinary Group/Medical Research Council Testicular Cancer Study Group (30941/TE20

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Ifosfamide encephalopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Ifosfamide extrapyramidal neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Bleomycin-induced pneumonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Lung damage from cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Pulmonary function in long-term survivors of testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular cancer: not only a bleomycin effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Severe bleomycin lung toxicity: reversal with high dose corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Raynaud's Phenomenon: A Common Toxicity After Combination Chemotherapy for Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Hypomagnesemia, renal dysfunction, and Raynaud's phenomenon in patients treated with cisplatin, vinblastine, and bleomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term renal function after treatment for malignant germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term sequelae of treatment for testicular germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Platinum organ toxicity and possible prevention in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Effects of cisplatin on different measures of glomerular function in the human kidney with special emphasis on high-dose.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Young age and the risk for ifosfamide-induced nephrotoxicity: a critical review of two opposing studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Association between long-term neuro-toxicities in testicular cancer survivors and polymorphisms in glutathione-s-transferase-P1 and -M1, a retrospective cross sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

High frequency audiometry in prospective clinical research of ototoxicity due to platinum derivatives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Mechanisms of cisplatin ototoxicity and progress in otoprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Megalin genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Glutathione S-transferase genetic polymorphisms and individual sensitivity to the ototoxic effect of cisplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Increased incidence of testicular cancer in men presenting with infertility and abnormal semen analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Fertility and offspring sex ratio of men who develop testicular cancer: a record linkage study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Impact of cytotoxic treatment on long-term fertility in patients with germ-cell cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Testicular function in patients with testicular cancer treated with bleomycin-etoposide-carboplatin (BEC(90)) combination chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Mechanisms of toxic damage to spermatogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Paternity following treatment for testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Fertility, gonadal and sexual function in survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

American Society of Clinical Oncology recommendations on fertility preservation in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Second malignancies among survivors of germ-cell testicular cancer: A pooled analysis between 13 cancer registries

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Second cancers after testicular cancer diagnosed after 1980 in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term complications of chemotherapy for germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Osteosarcomas and adult soft tissue sarcomas: Is there a place for high LET radiation therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Mortality after cure of testicular seminoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Myocardial infarction following vinblastine treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Etoposide-related myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Cardiovascular risk in long-term survivors of testicular cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) Study, 1987-1993.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Cardiovascular issues in hypogonadism and testosterone therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

HYPOGONADISM AND METABOLIC SYNDROME: IMPLICATIONS FOR TESTOSTERONE THERAPY

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Sex hormones, inflammation and the metabolic syndrome: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Nontraumatic osteonecrosis after chemotherapy for testicular cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

The prevalence of avascular necrosis in patients treated with chemotherapy for testicular tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term cognitive function following chemotherapy in patients with testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Study of anxiety disorder and depression in long-term survivors of testicular cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Fecundity and Twinning Rates as Measures of Fertility Before Diagnosis of Germ-Cell Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Treatment-Associated Leukemia Following Testicular Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Incidence of testicular germ cell cancers in U.S. children: SEER program experience 1973 to 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Randomized comparison of cisplatin and etoposide and either bleomycin or ifosfamide in treatment of advanced disseminated germ cell tumors: an Eastern Cooperative Oncology Group, Southwest Oncology Group, and Cancer and Leukemia Group B Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Equivalence of three or four cycles of bleomycin, etoposide, and cisplatin chemotherapy and of a 3- or 5-day schedule in good-prognosis germ cell cancer: a randomized study of the European Organization for Research and Treatment of Cancer Genitourin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Weighing the hazards of erythropoiesis stimulation in patients with cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Severe bleomycin-induced pneumonitis. Clinical features and response to corticosteroids

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Chemotherapy-induced eosinophilic pneumonia. Relation to bleomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Detecting bleomycin pulmonary toxicity: a continued conundrum

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Pulmonary complications associated with combination chemotherapy programs containing bleomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Pulmonary toxicity after treatment with bleomycin alone or in combination with hyperoxia. Studies in the rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Effect of ABVD chemotherapy with and without mantle or mediastinal irradiation on pulmonary function and symptoms in early-stage Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Enhanced effects of bleomycin on pulmonary function disturbances in patients with decreased renal function due to cisplatin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Bleomycin causes alveolar macrophages from cigarette smokers to release hydrogen peroxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Lack of late toxicity in patients treated with cisplatin-containing combination chemotherapy for metastatic testicular cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Bleomycin and Raynaud's phenomenon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Evaluation of long-term toxicity after chemotherapy for testicular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Long-term effects of chemotherapy in patients with testicular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

The long-term effect of cisplatin on renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

The renal pathology in clinical trials of cis-platinum (II) diamminedichloride

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Creatinine clearance as a predictor of ultrafilterable platinum disposition in cancer patients treated with cisplatin: relationship between peak ultrafilterable platinum plasma levels and nephrotoxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Increased plasma renin and aldosterone in patients treated with cisplatin-based chemotherapy for metastatic germ-cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Randomized trial of bleomycin, etoposide, and cisplatin compared with bleomycin, etoposide, and carboplatin in good-prognosis metastatic nonseminomatous germ cell cancer: a Multiinstitutional Medical Research Council/European Organization for Resear

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Neurotoxicity of oxaliplatin and cisplatin for dorsal root ganglion neurons correlates with platinum-DNA binding

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Semen quality and reproductive hormones before orchiectomy in men with testicular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Fertility after chemotherapy for testicular germ cell cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Gonadal dysfunction in patients treated for metastatic germ-cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Fertility after testicular cancer treatments: results of a large multicenter study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Paternity in men with stage I testis tumors on surveillance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Secondary neoplasms following treatment of malignant germ cell tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Second cancer risk following testicular cancer: a follow-up study of 1,909 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Secondary tumours following etoposide containing therapy for germ cell cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Acute nonlymphocytic leukemia in germ cell tumor patients treated with etoposide-containing chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Blood pressure and body mass index in long-term survivors of testicular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Components of the metabolic syndrome in long-term survivors of testicular cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Syndrome X in testicular-cancer survivors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

Groin pain in athletes: a consequence of femoral head avascular necrosis after testicular cancer chemotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

A prospective study of neuropsychological functioning in testicular cancer patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRUROL.2011.26

International Germ Cell Consensus Classification: a prognostic factor-based staging system for metastatic germ cell cancers. International Germ Cell Cancer Collaborative Group

31 March 2020

1 reference

12 December 2020

Ifosfamide/mesna related encephalopathy: a case report with a possible role of phenobarbital in enhancing neurotoxicity.

1 reference

12 December 2020

Effects of mannitol or furosemide diuresis on the nephrotoxicity and physiological disposition of cis-dichlorodiammineplatinum-(II) in rats

1 reference

12 December 2020

The approach to the patient with synchronous bilateral germ cell tumors: a lesson in oncologic prioritization.

1 reference

12 December 2020

The pulmonary toxicity of antineoplastic agents

1 reference

12 December 2020

Complications of therapy for testicular cancer

1 reference

12 December 2020

Risk factors for long-term outcome of ifosfamide-induced nephrotoxicity in children

1 reference

12 December 2020

Strategies to prevent nephrotoxicity of anticancer drugs

1 reference

12 December 2020

Long-term neurologic and peripheral vascular toxicity after chemotherapy treatment of testicular cancer.

1 reference

12 December 2020

Hematopoietic growth factors and treatment of testicular cancer: biological interactions, routine use and dose-intensive chemotherapy

1 reference

12 December 2020

Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study

1 reference

12 December 2020

Avascular necrosis of bone caused by combination chemotherapy without corticosteroids

1 reference

12 December 2020

Osteonecrosis in patients with testicular tumours treated with chemotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRUROL.2011.26

1 reference

24 August 2017

1 reference

PubMed ID

21403662